GLP-1 Agonists: A Comprehensive Overview
US$ 26.45
glp-1 drug shortages How drugs are used GLP-1 Drug Shortages - Endocrinology
Description
10.1172/jci1349
A study shows that GLP-1 receptor agonists show a notably reduced incidence of primary open-angle glaucoma (POAG), ocular hypertension, and the requirement for first-line glaucoma treatments compared to metformin in individuals with type 2 diabetes (80)
Kushner RF, Calanna S, Davies M, et al
Availability of data and materials Meta-analysis data is provided within the manuscript or supplementary information files
The complex interplay between diabetes and cancer risk presents additional challenges in understanding the role of GLP-1RAs
